{"id":"NCT00340834","sponsor":"Novartis","briefTitle":"Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase","officialTitle":"A 12-month Double-blind, Randomized, Multicenter, Active-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Interferon ß-1a (Avonex) Administered im Once Weekly in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05","primaryCompletion":"2011-07","completion":"2011-07","firstPosted":"2006-06-21","resultsPosted":"2011-05-16","lastUpdate":"2017-09-21"},"enrollment":1292,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"Fingolimod 1.25 mg","otherNames":["FTY720"]},{"type":"DRUG","name":"Fingolimod 0.5 mg","otherNames":["FTY720"]},{"type":"DRUG","name":"Interferon β-1a 30 µg","otherNames":[]}],"arms":[{"label":"Fingolimod 1.25 mg","type":"EXPERIMENTAL"},{"label":"Fingolimod 0.5 mg","type":"EXPERIMENTAL"},{"label":"Interferon β-1a 30 µg","type":"ACTIVE_COMPARATOR"}],"summary":"This study assessed the safety, tolerability, and efficacy of 2 doses of oral fingolimod versus interferon β-1a to reduce the frequency of relapses in patients with relapsing-remitting multiple sclerosis.","primaryOutcome":{"measure":"Estimated Annualized Aggregate Relapse Rate (ARR) in the Core Phase of the Study","timeFrame":"Baseline to Month 12","effectByArm":[{"arm":"Fingolimod 1.25 mg","deltaMin":0.203,"sd":null},{"arm":"Fingolimod 0.5 mg","deltaMin":0.161,"sd":null},{"arm":"Interferon β-1a µg/Fingolimod 1.25 or 0.5 mg","deltaMin":0.331,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":170,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Egypt","France","Germany","Greece","Hungary","Italy","Portugal","South Korea","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["26111826","25876473","25245812","23531349","21571593","20937112","20089954"],"seeAlso":["http://www.msclinicaltrials.com","http://www.nejm.org"]},"adverseEventsSummary":{"seriousAny":{"events":45,"n":420},"commonTop":["Nasopharyngitis","Headache","Influenza like illness","Fatigue","Upper respiratory tract infection"]}}